Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world data-Reference-Cited by-同舟云学术

Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world data

Published:2020-02 Issue:3 Volume:9 Page:155-159
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Seewald Michael J¹,Plumb Jonathan M²,Gutierrez Ben³,Liwing Johan⁴,Tepie Maurille Feudjo⁵,Hammer Mette⁶,LoCasale Robert⁷,Khosla Sajan⁸,Yin Donald⁹,Pashos Chris L¹⁰,Nagy Mark¹¹

Affiliation:

1. Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland

2. Ferring Pharmaceuticals SA, St Prex, Switzerland

3. GSK, Philadelphia, PA, USA

4. Janssen, Stockholm, Sweden

5. Center for Observational Research, Amgen, Cambridge, UK

6. Novo Nordisk, Copenhagen, Denmark

7. Sanofi, Bridgewater, NJ, USA

8. Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK

9. Merck, Kenilworth, NJ, USA

10. AbbVie, Chicago, IL, USA

11. Lilly, Indianapolis, IN, USA

Abstract

This White Paper is authored by 11 industry real-world evidence (RWE) experts, with support from IQVIA, as part of the ‘RWE Leadership Forum’: a group of industry leaders who come together as noncompetitive partners to understand and respond to internal or external RWD/E challenges and opportunities with a single expert voice. Herein we aim to clarify the rules of engagement between pharma and healthcare in order to establish trust-based partnerships, which will unlock unique value for society, including the medical community and the ultimate beneficiary, the patient.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2019-0183

Reference13 articles.

1. Toward a science of learning systems: a research agenda for the high-functioning Learning Health System

2. Public–private partnerships as enablers of progress in the fight against mental disorders: The example of the European Innovative Medicines Initiative

3. Harmony-alliance.euAlgorithms To Transform Knowledge Into Better Medicine Outcomes. (2019). https://www.harmony-alliance.eu/en/news/wp7/algorithms-to-transform-knowledge-into-better-medicine-outcomes

4. Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Journal of Comparative Effectiveness Research welcoming the submission of study design protocols to foster transparency and trust in real-world evidence;Journal of Comparative Effectiveness Research;2023-01

2. Introducing Volume 10 of the Journal of Comparative Effectiveness Research;Journal of Comparative Effectiveness Research;2021-01